{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:27:27Z","timestamp":1772166447616,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sichuan Provincial Science and Technology Department Central Guidance Local Projects","award":["2023ZYD0122"],"award-info":[{"award-number":["2023ZYD0122"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241036"],"award-info":[{"award-number":["82241036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neonatal respiratory distress syndrome (NRDS) is a life-threatening condition marked by progressive respiratory failure due to pulmonary surfactant (PS) deficiency, typically presenting within hours of birth. Exogenous pulmonary surfactant replacement therapy has significantly reduced mortality associated with NRDS and improved clinical outcomes. The current standard of care involves the intubation-surfactant-extubation (INSURE) technique. However, emerging evidence suggests that the laryngeal mask airway (LMA) may serve as a viable noninvasive alternative for neonatal resuscitation and therapeutic administration. This randomized controlled equivalence trial aims to compare the clinical efficacy and safety profiles of LMA and INSURE in delivering PS for NRDS management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Some of the preterm infants diagnosed with NRDS and requiring the first treatment with PS were included in this study. The included subjects were randomly assigned to the LMA group (experimental group) and the INSURE group (control group) by means of envelopes, and were given PS treatment by LMA or INSURE, respectively, and the SF index (SpO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      ) before and after the use of PS; the placement time of artificial airway, the episodes of hypoxemia, bradycardia and tachycardia during artificial airway placement; the amount of PS residue in the stomach after the use of PS; the incidence of the second use of PS, and the incidence of pneumothorax were also monitored in order to compare the effect and prognosis of the two methods of treating NRDS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The use of PS with INSURE is currently the most prominent and classic method. Although some recent studies suggest that non-invasive use of PS through a laryngeal mask is also effective,\u00a0relevant research\u00a0remains limited. Through this trial, we aim to gather more data regarding the use of PS with a laryngeal\u00a0mask and further validate its effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Name of the registry: A randomized controlled trial of pulmonary surfactant administration via laryngeal mask airway versus endotracheal intubation.<\/jats:p>\n                    <jats:p>Trial identifying number: ChiCTR2500096315.<\/jats:p>\n                    <jats:p>Date of registration in primary registry: 2025-01-21 00:00:00.<\/jats:p>\n                    <jats:p>PID: 254631.<\/jats:p>\n                    <jats:p>Country of recruitment: China.<\/jats:p>\n                    <jats:p>\n                      URL of trial registry record:\u00a0\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.html?proj=254631\" ext-link-type=\"uri\">https:\/\/www.chictr.org.cn\/showproj.html?proj=254631<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09310-x","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T04:24:20Z","timestamp":1764649460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A randomized controlled equivalence trial of pulmonary surfactant administration via laryngeal mask airway versus endotracheal intubation"],"prefix":"10.1186","volume":"27","author":[{"given":"Aoyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"8159","key":"9310_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0140-6736(80)90489-4","volume":"1","author":"T Fujiwara","year":"1980","unstructured":"Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980;1(8159):55\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(80)90489-4. PMID: 6101413.","journal-title":"Lancet"},{"issue":"4","key":"9310_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.21037\/tp-22-8","volume":"11","author":"Z Yi","year":"2022","unstructured":"Yi Z, Tan Y, Liu Y, Jiang L, Luo L, Wang L, Lei W, Tan J, Yan R. A systematic review and meta-analysis of pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome. Transl Pediatr. 2022;11(4):526\u201336. https:\/\/doi.org\/10.21037\/tp-22-8. PMCID: PMC9085948.","journal-title":"Transl Pediatr"},{"issue":"4","key":"9310_CR3","first-page":"3642","volume":"13","author":"H You","year":"2021","unstructured":"You H, Huang X. Effect of pulmonary surfactant on the prevention of neonatal respiratory distress syndrome in premature infants. Am J Transl Res. 2021;13(4):3642\u20139 PMID: 34017546; PMCID: PMC8129273.","journal-title":"Am J Transl Res"},{"issue":"1","key":"9310_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/pch\/pxaa116","volume":"26","author":"EH Ng","year":"2021","unstructured":"Ng EH, Shah V. Guidelines for surfactant replacement therapy in neonates. Paediatr Child Health. 2021;26(1):35\u201349. https:\/\/doi.org\/10.1093\/pch\/pxaa116. PMID: 33552321; PMCID: PMC7850281.","journal-title":"Paediatr Child Health"},{"issue":"1","key":"9310_CR5","first-page":"28","volume":"84","author":"D Trevisanuto","year":"2013","unstructured":"Trevisanuto D, Marchetto L. Minimally invasive approaches for surfactant administration. Acta Biomed. 2013;84(1):28\u201331 PMID: 24049959.","journal-title":"Acta Biomed"},{"issue":"5","key":"9310_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/archdischild-2020-319763","volume":"106","author":"I Bellos","year":"2021","unstructured":"Bellos I, Fitrou G, Panza R, Pandita A. Comparative efficacy of methods for surfactant administration: a network meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2021;106(5):474\u201387. https:\/\/doi.org\/10.1136\/archdischild-2020-319763. PMID: 33452218.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"9310_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0032-1323592","volume":"30","author":"JT Attridge","year":"2013","unstructured":"Attridge JT, Stewart C, Stukenborg GJ, Kattwinkel J. Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial. Am J Perinatol. 2013;30(3):201\u20136. https:\/\/doi.org\/10.1055\/s-0032-1323592. Epub 2012 Aug 14. PMID: 22893557.","journal-title":"Am J Perinatol"},{"issue":"3","key":"9310_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/jp.2015.177","volume":"36","author":"JM Pinheiro","year":"2016","unstructured":"Pinheiro JM, Santana-Rivas Q, Pezzano C. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery. J Perinatol. 2016;36(3):196\u2013201. https:\/\/doi.org\/10.1038\/jp.2015.177. Epub 2015 Dec 3. PMID: 26633145.","journal-title":"J Perinatol"},{"issue":"1","key":"9310_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ppul.25698","volume":"57","author":"U Devi","year":"2022","unstructured":"Devi U, Roberts KD, Pandita A. A systematic review of surfactant delivery via laryngeal mask airway, pharyngeal instillation, and aerosolization: methods, limitations, and outcomes. Pediatr Pulmonol. 2022;57(1):9\u201319. https:\/\/doi.org\/10.1002\/ppul.25698. Epub 2021 Sep 29. PMID: 34559459.","journal-title":"Pediatr Pulmonol"},{"issue":"19","key":"9310_CR10","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1080\/14767058.2016.1248938","volume":"30","author":"I Vannozzi","year":"2017","unstructured":"Vannozzi I, Ciantelli M, Moscuzza F, Scaramuzzo RT, Panizza D, Sigali E, et al. Catheter and laryngeal mask endotracheal surfactant therapy: the CALMEST approach as a novel MIST technique. J Matern Fetal Neonatal Med. 2017;30(19):2375\u20137. https:\/\/doi.org\/10.1080\/14767058.2016.1248938.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"9310_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jpeds.2017.09.068","volume":"193","author":"KD Roberts","year":"2018","unstructured":"Roberts KD, Brown R, Lampland AL, Leone TA, Rudser KD, Finer NN, et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial. J Pediatr. 2018;193:40-46.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.09.068.","journal-title":"J Pediatr"},{"issue":"1","key":"9310_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41372-018-0238-0","volume":"39","author":"AJ Groberg","year":"2019","unstructured":"Groberg AJ, Dintaman JM. Can laryngeal mask airway be used for surfactant administration in neonates? J Perinatol. 2019;39(1):8\u201310. https:\/\/doi.org\/10.1038\/s41372-018-0238-0.","journal-title":"J Perinatol"},{"issue":"4","key":"9310_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jped.2016.08.007","volume":"93","author":"RF Barbosa","year":"2017","unstructured":"Barbosa RF, Sim\u00f5es E Silva AC, Silva YP. A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates. J Pediatr (Rio J). 2017;93(4):343\u201350. https:\/\/doi.org\/10.1016\/j.jped.2016.08.007.","journal-title":"J Pediatr (Rio J)"},{"issue":"3","key":"9310_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/archdischild-2020-320438","volume":"106","author":"NJ Smee","year":"2021","unstructured":"Smee NJ, Boyd D, Conetta H, O\u2019Shea J. Laryngeal mask airway surfactant administration: case series of 60 infants. Arch Dis Child Fetal Neonatal Ed. 2021;106(3):342. https:\/\/doi.org\/10.1136\/archdischild-2020-320438.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"9310_CR15","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.137875","volume":"3","author":"A Sadeghnia","year":"2014","unstructured":"Sadeghnia A, Tanhaei M, Mohammadizadeh M, Nemati M. A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams. Adv Biomed Res. 2014;3(1):160. https:\/\/doi.org\/10.4103\/2277-9175.137875.","journal-title":"Adv Biomed Res"},{"issue":"1","key":"9310_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15753","volume":"66","author":"S Tsurukawa","year":"2024","unstructured":"Tsurukawa S, Zuiki M, Naito Y, Kitamura K, Matsumura U, Kanayama T, et al. Oxygenation saturation index in neonatal hypoxemic respiratory failure. Pediatr Int. 2024;66(1):e15753. https:\/\/doi.org\/10.1111\/ped.15753.","journal-title":"Pediatr Int"},{"issue":"1","key":"9310_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PCC.0b013e3181b0653d","volume":"11","author":"NJ Thomas","year":"2010","unstructured":"Thomas NJ, Shaffer ML, Willson DF, Shih MC, Curley MA. Defining acute lung disease in children with the oxygenation saturation index. Pediatr Crit Care Med. 2010;11(1):12\u20137. https:\/\/doi.org\/10.1097\/PCC.0b013e3181b0653d.","journal-title":"Pediatr Crit Care Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09310-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:46:17Z","timestamp":1767789977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09310-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9310"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09310-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6288978\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Ethics Committee of West China Second Hospital (approval number 2023 (241)). Patients will be enrolled after obtaining informed consent from either the patient or their next of kin, or, in the case of an emergency procedure, deferred consent from the patient. The informed consent form will be prepared by the principal investigator and guided, modified, and adjusted according to the guidelines of the hospital\u2019s ethics committee or review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"11"}}